UBS Group’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $44.7K | Buy |
|
|||||
|
2025
Q3 | $4.94K | Buy |
|
|||||
|
2025
Q2 | $2.63K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $951 | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.02K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.7K | Buy |
|
|||||
|
2023
Q3 | $1.88K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.26K | Sell |
|
|||||
|
2022
Q4 | $5.22K | Sell |
|
|||||
|
2022
Q3 | $22K | Sell |
|
|||||
|
2022
Q2 | $18K | Buy |
|
|||||
|
2022
Q1 | $20K | Buy |
|
|||||
|
2021
Q4 | $5K | Hold |
|
|||||
|
2021
Q3 | $8K | Hold |
|
|||||
|
2021
Q2 | $24K | Buy |
|